-
2023-505509-18-00
5
2017-07-12
mature aggressive B-cell lymphoma and leukemia in children and adolesc
-
2025-521764-35-01
5
2026-01-27
acute pharyngitis
-
2023-503289-22-00
4
2024-07-05
Relapsing Multiple Sclerosis
-
2022-503013-32-00
4
2024-01-29
ER-positive/HER2-negative early breast cancer
-
2022-502208-64-00
4
2023-11-25
Asthma
-
2023-505558-16-00
5
2023-10-24
Atopic Dermatitis
-
2023-510317-26-00
4
2023-02-07
Amyotrophic Lateral Sclerosis
-
2023-508528-36-00
5
2022-12-16
Resected squamous cell carcinoma of the head and neck
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2024-519227-22-00
9
2022-11-03
Myeloproliferative neoplasm in accelerated phase (MPN-AP)
-
2024-513082-39-00
4
2022-04-26
Locally Advanced Head & Neck Squamous Cell Carcinoma
-
2024-511071-16-00
3
2022-02-10
Solid Tumours
-
2023-506589-30-00
5
2022-02-09
Invasive Extraintestinal Pathogenic Escherichia coli Disease
-
2023-510441-24-00
5
2022-01-28
Graft Vs Host Disease
Peripheral Blood Stem Cell Transplantation
AML
M
-
2023-508511-23-00
5
2021-12-02
Amyotrophic Lateral Sclerosis (ALS)
-
2023-510162-27-00
4
2021-08-18
Chronic venous ulcers (CVU)
-
2024-513373-43-00
5
2021-06-11
Short bowel syndrome
-
2023-508259-38-00
5
2021-04-29
Adult patients with relapsed or primary refractory DLBCL
-
2023-506715-18-00
5
2019-12-04
colon cancer stage II, rectal cancer stage II
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2024-513374-22-00
5
2019-04-30
Short Bowel Syndrome
-
2022-502747-35-00
5
2019-02-18
Newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ova
-
2022-502909-15-00
4
2017-06-09
Metastatic Castration-Resistant Prostate Cancer
-
2024-511235-10-00
5
2016-07-25
Generalized mantle cell Lymphoma